Skip to main content
Premium Trial:

Request an Annual Quote

Coda Genomics Changes Name to Verdezyne

NEW YORK (GenomeWeb News) – Coda Genomics today announced that it has changed its name to Verdezyne.
 
The Laguna Hills, Calif.-based firm uses computational methods to design and synthesize gene libraries for engineering proteins, metabolic pathways, and microorganisms. Its technologies are used to optimize commercial fermentation processes, which are applied to manufacturing platform chemicals and biofuels.
 
The company was founded in 2005 and is privately held.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.